GWG Holdings, Inc.
Limited financial coverage for GWGHQ.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
GWG Holdings, Inc. operated as a financial services enterprise that specialized in delivering diverse liquidity solutions and related services to individuals holding illiquid alternative assets across a broad international scope, including North America, Asia, Western Europe, and both Latin and South America. The firm was structured into two primary divisions: Secondary Life Insurance and Beneficient.
- CEO
- Jeffrey S. Stein
- IPO
- 2014
- Employees
- 160
- HQ
- Dallas, TX, US
Get TickerSpark's AI analysis on GWGHQ
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $6.49
- 52W Low
- $0.01
- 50D MA
- $0.06
- 200D MA
- $1.01
- Beta
- 0.37
- RSI (14)
- 6
- Avg Volume
- 107
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
GWG said Q3 reflected solid life-settlement maturities, continued L Bond fundraising, and ongoing pivot toward Beneficient’s alternative-asset liquidity business.· November 23, 2020
- Life insurance portfolio saw just under $40 million of maturities, which management said compared favorably with prior quarters.
- GWG raised right at $115 million in L Bond sales in Q3, including a $43 million month in September.
- Beneficient closed $8.1 million in originations in October and said it had about a $300 million origination pipeline.
- Management emphasized new risk tools, including TotalAlt and AltRating, to manage and score alternative-asset collateral.
- GWG reiterated that it is moving away from life settlements toward alternative assets through Beneficient because policy yields have declined and competition has increased.
Management said total assets were in excess of $3.6 billion and stockholders’ equity was in excess of $400 million, with the balance sheet “still in line with where we were last quarter.” They also said the company reported a 69% debt coverage ratio under the L Bond indenture, below the 90% threshold. No revenue, EPS, or gross margin figures were provided in the call excerpt, and no explicit next-quarter or full-year financial guidance was given. Operationally, GWG reported just under $40 million of life insurance portfolio maturities in the quarter and right at $115 million of L Bond sales in Q3, including $43 million in September; Beneficient closed $8.1 million in originations in October and had about a $300 million pipeline.
Murray Holland framed the quarter as one of execution on the company’s strategic shift. He said GWG has been moving away from life settlements since 2018 because the market has become more competitive and policy yields no longer create enough spread, while Beneficient is seeing “considerably higher yields.” He also highlighted new oversight steps, including outside accounting firms for quarterly valuations, loan-portfolio opinions, internal audit consulting, and review of financing cost basis and related loan balances.
Tim Evans focused on balance sheet strength and covenant coverage, saying assets were above $3.6 billion and stockholders’ equity above $400 million. He noted the 69% debt coverage ratio versus the 90% limit in the L Bond indenture and pointed investors to quarterly disclosure for asset valuation methodology. On the portfolio side, he said the life-settlement book was still performing as expected under the longest-life-expectancy/actual-to-expected methodology through Q3.
Investors asked about L Bond coverage in a liquidation, and management said the indenture requires indebtedness to stay below 90% of assets; the reported quarter-end debt coverage ratio was 69%. Another question asked whether the life-settlement portfolio was progressing as expected, and Tim Evans said it was, citing the longest-life-expectancy methodology and actual-to-expected performance through Q3. Murray also answered a broader business-model question by saying GWG is intentionally shifting capital toward Beneficient and other alternative assets because the life-settlement business has become too competitive and yields have declined.
The call pointed to continued capital raising, with $115 million of L Bond sales in the quarter, plus a meaningful Beneficient pipeline of about $300 million. Management also sounded constructive on the new alternative-asset platform, saying the company has built products, systems, and risk tools that should support scaling in 2021.
The biggest risk discussed was the continued deterioration of the life-settlement market, where management said competition has increased and yields have fallen enough to reduce the business’s attractiveness. The call also showed that Beneficient is still early in development, with only $8.1 million of October originations versus a much larger stated pipeline, and the company did not provide revenue or earnings figures in this excerpt.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 0.0%
- Shares Outstanding
- 20.76M
- Float Shares
- 0
Buy/sell ratio 1.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 10, 22 | Tucker Michael A | other | 0 |
| Dec 10, 22 | Tucker Michael A | other | 0 |
| Jun 20, 22 | Stein Jeffrey Scott | other | 0 |
| Jun 20, 22 | Horton Anthony R | other | 0 |
| Oct 23, 20 | Stahl John A. | other | 0 |
| Sep 3, 20 | Fine Daniel Phillip | other | 0 |
| Sep 3, 20 | Gruber David S | other | 0 |
| Jun 18, 20 | Schnitzer Bruce William | other | 8,169 |
| Jun 18, 20 | Schnitzer Bruce William | other | 8,169 |
| Jun 18, 20 | LOCKHART DENNIS P | other | 8,169 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our GWGHQ coverage
Recent articles, reports, and earnings notes.
No research on GWGHQ yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GWGHQ report →Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.